Market Overview

Global Biologic Therapeutics Market Outlook to 2027 - Rising Reimbursement for Biologic Therapeutics

Share:

Global Biologic Therapeutics Market Outlook to 2027 - Rising Reimbursement for Biologic Therapeutics

PR Newswire

DUBLIN, Aug 2, 2018 /PRNewswire/ --

The "Global Biologic Therapeutics Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Biologic Therapeutics Market is poised to grow strong during the forecast period 2017 to 2027.

Some of the prominent trends that the market is witnessing include rising reimbursement for biologic therapeutics, increasing applications of biologics and growing research and development in the pharmaceutical sector.

Based on Product, the market is classified into blood products, human cells and tissues, protein, xenotransplantation products, vaccines, allergenic extracts, gene therapies and cellular therapies.

Depending upon Application, market is divided into rheumatoid arthritis, cancer, anemia, diabetes and other applications.


Report Highlights

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Application Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Rising Reimbursement for Biologic Therapeutics
3.1.2 Increasing Applications of Biologics
3.1.3 Growing Research and Development in the Pharmaceutical Sector
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Biologic Therapeutics Market, By Product
4.1 Blood Products
4.1.1 Blood Products Market Forecast to 2027 (US$ MN)
4.2 Human Cells and Tissues
4.2.1 Human Cells and Tissues Market Forecast to 2027 (US$ MN)
4.3 Protein
4.3.1 Protein Market Forecast to 2027 (US$ MN)
4.4 Xenotransplantation Products
4.4.1 Xenotransplantation Products Market Forecast to 2027 (US$ MN)
4.5 Vaccines
4.5.1 Vaccines Market Forecast to 2027 (US$ MN)
4.6 Allergenic Extracts
4.6.1 Allergenic Extracts Market Forecast to 2027 (US$ MN)
4.7 Gene Therapies
4.7.1 Gene Therapies Market Forecast to 2027 (US$ MN)
4.8 Cellular Therapies
4.8.1 Cellular Therapies Market Forecast to 2027 (US$ MN)

5 Biologic Therapeutics Market, By Application
5.1 Rheumatoid Arthritis
5.1.1 Rheumatoid Arthritis Market Forecast to 2027 (US$ MN)
5.2 Cancer
5.2.1 Cancer Market Forecast to 2027 (US$ MN)
5.3 Anemia
5.3.1 Anemia Market Forecast to 2027 (US$ MN)
5.5 Diabetes
5.4.1 Diabetes Market Forecast to 2027 (US$ MN)
5.5 Other Applications
5.5.1 Other Applications Market Forecast to 2027 (US$ MN)

6 Biologic Therapeutics Market, By Geography
6.1 North America
6.1.1 North America Market Forecast by Countries to 2027 (US$ MN)
6.1.1.1 US
6.1.1.2 Canada
6.1.1.3 Mexico
6.2 Europe
6.2.1 Europe Market Forecast by Countries to 2027 (US$ MN)
6.2.1.1 Germany
6.2.1.2 U.K
6.2.1.3 Italy
6.2.1.4 France
6.2.1.5 Spain
6.2.1.6 Rest of Europe
6.3 Asia Pacific
6.3.1 Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
6.3.1.1 China
6.3.1.2 Japan
6.3.1.3 India
6.3.1.4 Australia
6.3.1.5 New Zealand
6.3.1.6 Rest of Asia Pacific
6.4 Middle East
6.4.1 Middle East Market Forecast by Countries to 2027 (US$ MN)
6.4.1.1 Saudi Arabia
6.4.1.2 UAE
6.4.1.3 Rest of Middle East
6.5 Latin America
6.5.1 Latin America Market Forecast by Countries to 2027 (US$ MN)
6.5.1.1 Argentina
6.5.1.2 Brazil
6.5.1.3 Rest of Latin America
6.6 Rest of the World (RoW)
6.6.1 RoW Market Forecast by Countries to 2027 (US$ MN)
6.6.1.1 South Africa
6.6.1.2 Others

7 Key Player Activities
7.1 Acquisitions & Mergers
7.2 Agreements, Partnerships, Collaborations and Joint Ventures
7.3 Product Launch & Expansions
7.4 Other Activities

8 Leading Companies
8.1 Novartis Global
8.2 Merck
8.3 GlaxoSmithKline
8.4 Pfizer
8.5 AstraZeneca
8.6 GlaxoSmithKline
8.7 Aurobindo Pharma
8.8 F. Hoffmann-La Roche
8.8 Amgen
8.10 Sanofi
8.11 Novo Nordisk A/S

For more information about this report visit https://www.researchandmarkets.com/research/8q2rwl/global_biologic?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 




Cision View original content:http://www.prnewswire.com/news-releases/global-biologic-therapeutics-market-outlook-to-2027---rising-reimbursement-for-biologic-therapeutics-300691124.html

SOURCE Research and Markets

View Comments and Join the Discussion!